Quest Diagnostics appoints Benjamin Beauvalot as strategy and M&A chief

Go back to Quest Diagnostics appoints Benjamin Beauvalot as strategy and M&A chief
Quest Diagnostics (NYSE: DGX) Delayed: 237.54 +1.70 (0.72%)
Previous Close $235.84    52 Week High $86.85 
Open $237.66    52 Week Low $59.66 
Day High $238.56    P/E 44.73 
Day Low $235.32    EPS $5.31 
Volume 263,951